This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • HIV/AIDS  • Sexually Transmitted Diseases  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The meta-analytic review by Dr Crepaz and colleagues¹ provides reassurance that neither HAART use nor viral load were associated with increased sexual risk behavior. This is welcome news for those engaged in accelerating access to HIV treatment, since a key premise of scale-up efforts is that treatment and prevention are mutually reinforcing.² However, we are concerned that these conclusions are not based on data from resource-poor settings, where the prevalence of HIV/AIDS is highest. Sixteen of the 25 studies sampled populations from the United States; the other 9 were from industrialized countries. Furthermore, gay men were overrepresented in the analysis, accounting for the totality of 12 samples and the majority of 3 others; intravenous drug users accounted for the totality of 2 additional studies. The authors note that heterosexual respondents receiving HAART were significantly less likely to engage in unprotected sex than untreated respondents, but this . . . [Full Text of this Article]

Carla Makhlouf Obermeyer, DSc
obermeyerc@who.int

Rahul Rajkumar, BA
World Health Organization
Geneva, Switzerland

RELATED ARTICLES

HAART and Sexual Risk Behavior
Catherine Diamond
JAMA. 2004;292(19):2335.
EXTRACT | FULL TEXT  

HAART and Sexual Risk Behavior—Reply
Nicole Crepaz, Gary Marks, and Trevor A. Hart
JAMA. 2004;292(19):2336.
EXTRACT | FULL TEXT  

Highly Active Antiretroviral Therapy and Sexual Risk Behavior: A Meta-analytic Review
Nicole Crepaz, Trevor A. Hart, and Gary Marks
JAMA. 2004;292(2):224-236.
ABSTRACT | FULL TEXT